Misonix Inc (NASDAQ:MSON)

23.94
Delayed Data
As of 3:59pm ET
 +0.54 / +2.31%
Today’s Change
11.04
Today|||52-Week Range
24.42
+91.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$391.7M

Company Description

Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.

Contact Information

Misonix, Inc.
1938 New Highway
Farmingdale New York 11735
P:(631) 694-9555
Investor Relations:

Employees

Shareholders

Individual stakeholders31.06%
Other institutional19.94%
Mutual fund holders13.32%

Top Executives

Stavros G. VizirgianakisChief Executive Officer & Director
Allan R. StaleyPresident
Sharon W. KlugewiczChief Operating Officer
Joseph P. DwyerChief Financial Officer, Secretary & Treasurer
Daniel VoicVP-Engineering, Research & Development